Q/C Technologies, Inc.
QCLS- Exchange
- Nasdaq
- Industry
- In Vitro & In Vivo Diagnostic Substances
- SEC CIK
- 0001321834
No open-market purchases or sales by Q/C Technologies, Inc. insiders were filed in the last 90 days; 21 institutions reported holding it in 13F filings for Q2 2026, worth $2.87M in total; no superinvestor holds it.
Q4 2022 vs. Q3 2022
How the institutions holding Q/C Technologies, Inc. changed between Q3 2022 and Q4 2022.
All holders in Q4 2022All holders in Q3 2022
| Measure | Q3 2022 | Q4 2022 | Change |
|---|---|---|---|
| Holders | 43 | 43 | 0 |
| Shares | 3.81M | 3.90M | +94.5K (+2.5%) |
| Value | $9.94M | $4.49M | −$5.45M (−54.8%) |
New holders (7)
Institutions that held Q/C Technologies, Inc. at the end of Q4 2022 but not at the end of Q3 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| International Assets Investment Management, LLC | 67,000 | $77.0K | 0.01% |
| Fidelis Capital Partners, LLC | 38,590 | $50.9K | 0.06% |
| Two Sigma Investments, LP | 30,084 | $34.6K | 0.00% |
| UBS Group AG | 7,312 | $8.41K | 0.00% |
| Advisory Services Network, LLC | 100 | $115 | 0.00% |
| Nelson, Van Denburg & Campbell Wealth Management Group, LLC | 100 | $115 | 0.00% |
| GWM Advisors LLC | 1 | $0 | 0.00% |
Sold out (7)
Institutions that held Q/C Technologies, Inc. at the end of Q3 2022 and filed for Q4 2022 without it.
| Institution | Shares, Q3 2022 | Value, Q3 2022 |
|---|---|---|
| Aaron Wealth Advisors | 50,000 | $131.0K |
| ExodusPoint Capital Management, LP | 34,456 | $90.0K |
| Cubist Systematic Strategies, LLC | 20,483 | $53.0K |
| Jane Street Group, LLC | 15,099 | $39.0K |
| Renaissance Technologies LLC | 10,492 | $27.0K |
| Newbridge Financial Services Group, Inc. | 250 | $1.00K |
| Allworth Financial LP | 100 | $0 |